Firm earns repeat national recognition from US News/Best Lawyers in America for work in patent infringement, intellectual property litigation HOUSTON – Heim, Payne & Chorush has again been named to the prestigious Best Law Firms in America listing by U.S. News & World Report and The Best Lawyers in America, one of the oldest and most respected legal listings in the industry. The Houston-based litigation boutique earned top rankings nationally and in the Houston legal market for work in patent
Read moreAttorneys recognized for litigation in intellectual property cases across wide range of industries HOUSTON – Four partners from Houston-based Heim, Payne & Chorush have been honored for their work in intellectual property litigation by Texas Super Lawyers following a rigorous peer-review and selection process to compile the prestigious 2021 list. Firm co-founder and managing director Mike Heim earned
Read moreTexas federal courts remain the venue of choice for high-stakes patent infringement litigation, with courts in the state’s Western and Eastern judicial districts reporting the largest number of filings in the U.S., according to a midyear analysis by Texas Lawbook newspaper. Patent owners filed 790 infringement complaints in Texas courts during the first half of
Read moreFirm co-founder Mike Heim named ‘Lawyer of the Year’ for patent litigation HOUSTON – Nine partners with Houston-based Heim, Payne & Chorush have been selected for the 28th edition of The Best Lawyers in America, including firm co-founder Mike Heim, who is singled out as Patent Litigation Lawyer of the Year in Houston. Mr. Heim received the Lawyer of the Year honor based on his experience as
Read moreHeim, Payne & Chorush co-founder Les Payne is among a select group of trial lawyers included in the National Law Journal’s 2021 list of “Plaintiffs’ Lawyers Trailblazers.” One of only 52 attorneys honored nationwide, Mr. Payne was selected based on his work on behalf of patent owners and businesses in patent infringement litigation at the trial court level,
Read moreHouston IP boutique described as ‘powerful and balanced team’ in exclusive rankings HOUSTON – Heim, Payne & Chorush and firm co-founders Mike Heim and Les Payne have earned repeat recognition from the prestigious Chambers USA legal guide, honored for their expertise in patent litigation. In the 2021 legal guide, the firm moved up in the rankings and is one of only 11 Texas ranked firms
Read moreHeim, Payne & Chorush partners Blaine Larson and Allan Bullwinkel have earned repeat selection to the Super Lawyers Rising Stars list of the state’s top young lawyers. The Texas Rising Stars list recognizes the outstanding work of the state’s top attorneys under the age of 40 or those who have practiced law for no more than 10
Read moreHeim, Payne & Chorush is a proud supporter of Weatherford International’s annual Weatherford Walks fundraiser. Although this year’s walkathon was forced to go virtual because of the pandemic, participants still logged nearly 3,300 miles throughout the entire month of November to raise awareness and more than $381,000 for four Houston-area nonprofits. Since its inception, Weatherford Walks has raised more than $2.28 million for
Read moreHouston IP boutique recognized for activity, performance in Patexia Insights analysis HOUSTON – Heim, Payne & Chorush is again ranked among the most-active and top–performing intellectual property law firms in the nation for critically important post-grant inter partes review proceedings based on a comprehensive analysis by Patexia Insights. The Houston-based patent litigation boutique is among the Top 100 in the U.S. in an analysis based on filings for patent owners, patent petitioners and case outcomes, as well as an overall category that aggregates all the variables. Results of
Read moreHouston patent litigation boutique recognized for role in record $750M Namenda settlement HOUSTON — Heim, Payne & Chorush, LLP, has earned the American Antitrust Institute’s 2020 Antitrust Enforcement Award for the firm’s role in a record $750 million settlement with pharmaceutical company Allergan in patent-related antitrust litigation related to the Alzheimer’s drug Namenda. The January
Read more
